SEINE BIO · SCIENCE LIBRARY
Wolverine stack
Wolverine is an informal recovery-stack nickname commonly used for BPC-157 plus TB-500-related material.
Nonstandard stack nameA closer look at the research, the uncertainties and the questions worth asking.
THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026
Inside the science of Wolverine stack.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is appropriate only when lawful for the specific substance and patient; some substances may be unavailable. Finished FDA-approved medicines may also be dispensed by licensed non-compounding pharmacies.
Overview
The Wolverine stack is an informal name usually associated with BPC-157 and TB-500. It is not a standardized, approved combination medicine. The name can conceal different formulations and ratios, and TB-500 is sometimes incorrectly treated as identical to full-length thymosin beta-4. Identifying the actual ingredients comes before evaluating any recovery claim.
Community Use
PeptideDosages publishes a BPC-157/TB-500 blend protocol, while Peptidepedia discusses the Wolverine pairing in a comparison guide. These are community interpretations rather than human combination trials. Their existence documents interest, not proof of faster injury recovery. Community blend protocol; Community comparison.
Doses, Durations & Cycles
Informal biohacking protocols and published regimens. Attributed website reports for education, not medical recommendations. Multiple publications document circulation; they do not establish a safe dose or validate a cycle.
| Route / formulation | Dose / reported phases | Frequency | Duration / break | Notes and source |
|---|---|---|---|---|
| Both subcutaneous | Weeks 1–4: BPC-157 250–500 mcg per day, often split AM/PM; TB-500 2–2.5 mg per injection. Weeks 5–8: BPC-157 250 mcg per day; TB-500 2 mg per injection. | Loading: BPC-157 daily, TB-500 twice weekly. Maintenance: BPC-157 once daily, TB-500 once weekly. | 8 weeks active dosing: 4 loading + 4 maintenance Break: 4 weeks (weeks 9–12) | Published informal biohacking claim PeptideProbe The publisher explicitly pairs both components in the same phase table and identifies the pairing as a community protocol rather than a human randomized-trial regimen. |
| Both subcutaneous | BPC-157 300–500 mcg per day; TB-500 2 mg per injection throughout, with frequency reduced during maintenance. | Days 1–28: BPC-157 every morning + TB-500 Monday and Thursday. Days 29–56: BPC-157 daily + TB-500 once weekly. | 8-week sample protocol Break: 4 weeks after the cycle | Published informal biohacking claim PeptideDeck This combination schedule is stated explicitly. The page also mentions 8–12-week courses in its FAQ; this claim records its concrete 8-week template. |
Important context: Two different publishers provide explicit paired doses and complete schedules. TB-500 uses a separate weekly schedule in these sources; neither source establishes a clinical average or safe maximum for the stack.
Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.
No validated human dose, combined ratio, or on/off cycle is established for the named stack. A total blend amount does not identify the amount of each constituent. A study of full-length thymosin beta-4 cannot supply a dose for a TB-500 fragment, nor validate the addition of BPC-157.
Research Findings
A frequently cited 1999 paper studied full-length thymosin beta-4 in cultured cells and rat wounds. It did not test the Wolverine blend in people. FDA’s 2026 assessment separately reviews the TB-500 fragment and its limited clinical evidence. Cell and rat wound study; FDA TB-500 assessment.
U.S. Approval & Access
The informal stack has no FDA-approved combination product established here. Committee review or a nomination for compounding is not drug approval. Each ingredient and formulation requires a lawful pathway; a stack nickname cannot bypass restrictions or guarantee that a pharmacy may supply it.
What It Does in the Body
The pairing is proposed to combine different recovery-related research mechanisms. That is a hypothesis, not demonstrated synergy. Reliable onset, peak benefit, and duration for a human Wolverine program are unknown; results from a single ingredient in animals do not answer those timing questions.
Benefits & Reported Experiences
Wound-related findings in a rat model are not evidence of healed human sports injuries after combined injections. The distinction is especially important when a promotional story promises rapid return to training. A measured human functional outcome for the actual combination would be needed to support that claim.
Side Effects & Risks
There is no adequate human combination safety profile established by the cited sources. Risks and uncertainties depend on the actual ingredients and formulations. Monitoring one ingredient cannot automatically characterize a blend, while a low complaint rate in a community discussion is not systematic adverse-event follow-up.
Delivery Options
Community protocols may describe injectable blends, but the primary wound paper does not validate their route or preparation. This library provides no mixing or injection instructions. Separate products and premixed blends also cannot be assumed equivalent simply because both are called Wolverine.
Product Quality & Storage
Require exact constituent identity and proportion when evaluating a claim. Purity and a combined milligram label do not establish human sterility, potency, effectiveness, or lawful dispensing. No consumer storage instructions are guessed for an unapproved blend; any authorized product would need its own verified directions.
Combinations & Interactions
This is already a proposed stack, not evidence that more ingredients should be added. Adding growth-hormone agents or anti-inflammatory research compounds increases the number of unanswered interaction questions. Evaluate the actual combination rather than assuming each individual mechanism contributes a predictable benefit.
Talking With Your Provider
Persistent pain or an injury that is not healing deserves a diagnosis and a rehabilitation plan. A clinician can review the research you encountered and discuss established options. The goal is safe recovery and measurable function, not obtaining a named blend regardless of evidence or legal availability.
Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.
Compounding is appropriate only when lawful for the specific substance and patient; some substances may be unavailable. Finished FDA-approved medicines may also be dispensed by licensed non-compounding pharmacies.
Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.
Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.
Questions worth bringing to your appointment.
- Are there alternatives that address my goal?
- If treatment is appropriate, what monitoring and follow-up would I need?
- Could my health history or current medicines change the risks?
Saved discussion topics 0
Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.
Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.
Explore your next step with SEINE BIO.
Bring your questions to a wellness consultation. Inclusion in this library does not indicate prescribing or product availability. A consultation does not guarantee a prescription.
Explore consultations Back to Blend names: GLOW & KLOWEducational information · U.S. context · October 7, 2026. No ordering, personalized dosing or injection instructions.
Bring your saved topics to your care team.
Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.
Choose saved topics for review →